TITLE

Simultaneous analysts of quality of life and survival data

AUTHOR(S)
Billingham, L.J.; Abrams, K.R.
PUB. DATE
February 2002
SOURCE
Statistical Methods in Medical Research;Feb2002, Vol. 11 Issue 1, p25
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a simultaneous analysis of quality of life and survival data. Comparison between treatment in each outcome and assessment of the net effect; Review of the techniques for quality-adjusted survival analysis; Means of accounting for the informative dropout due to the death of patients.
ACCESSION #
6663089

 

Related Articles

  • Health-Related Quality of Life Predictors of Survival and Hospital Utilization. Parkerson Jr., George R.; Gutman, Robert A. // Health Care Financing Review;Spring2000, Vol. 21 Issue 3, p171 

    The health-related quality of life (HRQOL) of 103 end-stage renal disease (ESRD) patients on hemodialysis was studied for prediction of 1-year survival and hospital days in the context of other predictors. Higher HRQOL physical functioning, higher provider-reported functional performance, fewer...

  • Medium-term survival and quality of life of Swedish octogenarians after open-heart surgery Collins, Sonia Maria; Brorsson, Bengt; Svenmarker, Staffan; Kling, Per Arne; Åberg, Torkel // European Journal of Cardio-Thoracic Surgery;Nov2002, Vol. 22 Issue 5, p794 

    Objective: Operative mortality after open-heart interventions in the octogenarian population is relatively well known. Less has been reported on the medium term survival and quality of life of this growing subgroup of patients. Methods: One hundred and eighty-three consecutive patients aged...

  • Fibrosis quística: aumento de la sobrevida en un centro especializado a 10 años de seguimiento. LENTINI N., EDUARDO; LÓPEZ-MILLÁN., ADRIANA; LORES L., ANA MARÍA; PESCIULLESI B., MARÍA ROSA; ITUARTE R., LEONOR MARÍA; VIERA C., TERESA BEATRIZ // Revista Chilena de Pediatría;2014, Vol. 85 Issue 3, p281 

    Introduction: Cystic fibrosis (CF), the most common genetic disease among whites, is a multisystem disease that requires a coordinated multidisciplinary approach to get better results regarding survival and quality of life. This is why a Cystic Fibrosis Center (CFC) was held in Mendoza,...

  • Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer. Sullivan, Patrick W.; Nelson, Joel B.; Mulani, Parvez M.; Sleep, Darryl // Quality of Life Research;Oct2006, Vol. 15 Issue 8, p1297 

    Background: The association between HRQL measures with outcomes in patients with metastatic hormone-refractory prostate cancer (HRPC) is unclear.Methods: Baseline and 12-week HRQL was collected using the European Organization for Research and Treatment of Cancer (EORTC...

  • Health-related quality of life as a prognostic factor of survival in critically ill patients. Iribarren-Diarasarri, Sebastián; Aizpuru-Barandiaran, Felipe; Muñoz-Martínez, Tomás; Loma-Osorio, Ángel; Hernández-López, Marianela; Ruiz-Zorrilla, José; Castillo-Arenal, Carlos; Dudagoitia-Otaolea, Juan; Martínez-Alutiz, Sergio; Vinuesa-Lozano, Cristina // Intensive Care Medicine;May2009, Vol. 35 Issue 5, p833 

    To evaluate whether health-related quality of life prior to admission into an intensive care unit (ICU) is a prognostic factor of hospital and 1 year mortality. Prospective cohort study. Fourteen-bed medical–surgical ICU. A total of 377 patients admitted to the ICU for more than 24 h with...

  • Shaping the future of biomarker research in breast cancer to ensure clinical relevance. Hinestrosa, M. Carolina; Dickersin, Kay; Klein, Pamela; Mayer, Musa; Noss, Karin; Slamon, Dennis; Sledge, George; Visco, Frances M. // Nature Reviews Cancer;Apr2007, Vol. 7 Issue 4, p309 

    Each year, over 200,000 people are diagnosed with breast cancer in the United States. Although the use of biomarkers has the potential to guide preventive interventions and improve survival and quality of life, there have been few successes and many disappointments. In November 2005, the...

  • DUGOROÄŒNO PREŽIVLJAVANJE I KVALITET ŽIVOTA NAKON HIRURÅ KE REVASKULARIZACIJE MIOKARDA U ODNOSU NA STAROST I POL. Redžek, Aleksandar; Šušak, Stamenko; Zečević, Dragan // Medicinski Pregled / Medical Review;2007, Vol. 60 Issue 7/8, p317 

    Introduction: Quality of life assessment and survival analysis are a "gold standard" in assessing treatment quality in general. In the absence of a universally accepted integral index, we developed our own QOLi-NS (Quality of Life Index - Novi Sad) as a disease specific index. The aim of this...

  • DUGOROÄŒNO PREŽIVLJAVANJE I KVALITET ŽIVOTA NAKON HIRURÅ KE REVASKULARIZACIJE MIOKARDA U ODNOSU NA STAROST I POL. Redžek, Aleksandar; Šušak, Stamenko; Zečević, Dragan // Medicinski Pregled / Medical Review;2007, Vol. 60 Issue 7/8, p317 

    Introduction: Quality of life assessment and survival analysis are a "gold standard" in assessing treatment quality in general. In the absence of a universally accepted integral index, we developed our own QOLi-NS (Quality of Life Index - Novi Sad) as a disease specific index. The aim of this...

  • A consistent estimator for the distribution of quality adjusted survival time. ZHAO, HONGWEI; TSIATIS, ANASTASIOS A. // Biometrika;1997, Vol. 84 Issue 2, p339 

    Quality adjusted survival analysis is a new approach to therapy evaluation in clinical trials. It has received much attention recently because of its ability to take patients' quality of life into consideration. In this paper, we present a method that enables us to calculate the survival...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics